STAT (blood flow measurement device to the head)

2023: Device Release

In mid-June 2023, the American company STAT Health released a device called STAT, capable of recognizing symptoms of loss of consciousness in advance. The device is suitable for users with heart disease, myalgic encephalomyelitis, chronic fatigue syndrome or experiencing severe side effects after suffering from COVID-19.

At the heart of the device, resembling a compact earphone, is monitoring the flow of blood to the head, which can be measured through vessels located in the auricle. The device uses an optical sensor to puncture a small ear artery to measure an indirect measure of cerebral blood flow obtained by ultrasound. It also includes an accelerometer, a pressure sensor, temperature sensors, edge AI calculations and a micro solar battery to maintain charge.

STAT device

According to STAT Health, users of the gadget can use other regular headsets from the market. During the day, the sensor collects diagnostic information and transmits it to the user's smartphone. The STAT application can show the preferential direction of blood flow with the words "Up" to the head and "Outflow" from the head. Software from STAT Health collects all information from the device and converts it into an estimate of time spent upright and a flow estimate that helps users speed up the recovery process by tracking abnormalities in the bloodstream.

After numerous engineering breakthroughs, we managed to combine the convenience and longevity of wearable devices with the high accuracy of intrusive clinical monitors. No other device approaches us in terms of wearability and cardio quality, "said STAT Health co-founder and CEO Daniel Lee.

The device completed clinical trials at the Johns Hopkins Clinic and received a review in the Journal of the American College of Cardiology. According to doctors, the preservation of health problems associated with COVID-19 has been of concern to doctors since 2019, who do not know how to treat patients. The problem is that because symptoms vary, there is no one-size-fits-all approach to treatment and may depend on how severe a person's illness was at the time of contracting the disease. Blood flow to the head is considered a key biomarker for this kind of disease, Dr. Benjamin Abramoff of the University of Pennsylvania Perelman School of Medicine reported. The information received from the STAT device can help medical staff better understand patients' symptoms and manage them faster.

STAT Health in 2023 received $5.1 million in seed funding from J2 Ventures, BonAngels Venture Partners and an angel investor group. In addition, the company received a grant from the US Air Force.^[1]

Notes